EIB Funding Fuels Chromafora’s Growth – Strong Performance in Q1 and Q2

Following a financing agreement with the European Investment Bank (EIB), which took effect at the end of 2024, Swedish cleantech company Chromafora has reported a strong first half of 2025. The company is seeing significantly increased demand, new business deals, and growing market confidence—driven by its unique Selpaxt technology, the only solution capable of selectively concentrating long, short, and ultra-short PFAS chains from complex water streams.

“The partnership with the EIB has truly been a gamechanger for Chromafora. It has provided us with both the financial resources and strategic support needed to accelerate our commercial growth and expand our market presence. This has been instrumental in delivering such strong results in the first half of the year, and we look forward to continuing to leverage the EIB’s backing to ensure our long-term success,” says Johan Seijmer, CEO of Chromafora.

In total, the European Investment Bank is providing €22.5 million in loan financing to support Chromafora’s efforts to combat PFAS—the so-called “forever chemicals”—in Europe. Demand for PFAS treatment is growing, and technologies like Selpaxt are gaining momentum, propelled by tightening EU legislation, especially around the safe handling of PFAS-contaminated leachate.

Selpaxt is currently the only platform on the market that can selectively concentrate all PFAS chain lengths—including ultra-short ones—from complex water matrices such as landfill leachate and industrial efflutents. The next strategic step is to integrate with PFAS destruction technologies.

“The market is not only looking for ways to capture PFAS but also to eliminate it. That’s why we are actively conducting tests to identify the destruction methods that best complement Selpaxt,” Seijmer explains.

The EIB’s initial disbursement of €5 million in Q1 enabled Chromafora to accelerate its expansion, particularly in the waste management and landfill sectors.

“Landfill leachate is one of the most common sources of high concentrations of hard-to-capture (short-chain) PFAS. These are notoriously difficult to treat due to the complexity of the water matrix. No other technology is as effective in treating PFAS in these streams as Selpaxt, and we’re very proud of that,” says Seijmer.

In Sweden, PFAS has been detected in 113 out of 117 landfills, which together discharge more than 7 million m³ of leachate annually. ¹ Across Europe, there are an estimated 185,000 landfills where Selpaxt could be deployed, each with a potential application value of around €1 million.

Key milestones during the first half of 2025:

• Repeat orders from Chromafora’s three largest customers, including system upgrades and new units
• Sharp increase in inbound inquiries from across Europe
• Partnership agreements signed with distributors in Germany and the Netherlands
• Increased European presence through trade shows and conferences, and the establishment of a new office in Brussels to improve customer integration and streamline processes
• Growing market trust in Chromafora’s capabilities, supported by the EIB’s financing approval following extensive due diligence and analysis
• Upgraded container-based pilot system to enable a wider range of membrane testing and more precise control of process parameters like pressure and flow
• Ongoing further development of Selpaxt chemistry to improve environmental performance, cost-efficiency, and treatment effectiveness

Sammantaget uppskattar bolaget ett potentiellt affärsvärde på över 75 miljoner euro bara hos kunder man redan samarbetar med, där fler än 100 vattenströmmar har identifierats som möjliga tillämpningar.

Overall, Chromafora estimates a business potential of over €75 million among its current customer base, where more than 100 water streams have already been identified as viable applications.

Earlier this year, Chromafora was awarded Frost & Sullivan’s 2025 Global New Product Innovation Award for Excellence in PFAS Water Treatment Solutions, recognizing the company’s role in setting a new benchmark for performance and innovation in advanced PFAS remediation.

Read the full Frost & Sullivans report.

¹ Miljösamverkan, 2022. Figure reflects data from studied landfills.

About SELPAXT by Chromafora
SELPAXT is a patented PFAS concentration technology developed by Chromafora for the selective removal of long, short, and ultra-short PFAS chains. The system combines ultrafiltration with proprietary selective chemistry that binds PFAS molecules, achieving removal rates above 90%, even in complex water streams with high levels of organic content (TOC).

The efficiency of the SELPAXT technology has been validated through studies conducted by the RISE Research Institutes of Sweden and pilot evaluations at selected landfill sites.

The process operates continuously and concentrates PFAS into a residual waste stream amounting to just 0.1% of the treated volume, greatly reducing waste handling needs.

SELPAXT has a modular design that can be easily integrated into existing treatment facilities, offering a robust, stable, and cost-efficient PFAS solution for industrial process water, landfill leachate, and other complex applications.